About Neovasc Inc.
Neovasc develops the Tiara transcatheter mitral valve replacement system and Reducer device for refractory angina, offering minimally invasive cardiac solutions.
📍 Location & Offices
📋 Request a Quote
Send your requirements directly to Neovasc Inc.. Response typically within 48 hours.
Company Info
TypePublic
StockNVCN (NASDAQ)
Founded2000
Employees80
Revenue$12M
HQRichmond, Canada
